Beckman Research Institute

2017–2022 · career development · K08

Investigation of 9-cis Retinoic Acid as a Novel Treatment for Post-Surgical Lymphedema

Alex K. Wong · Beckman Research Institute · funded by National Institutes of Health

$25.7kLymphatic System and Diseases

2017–2022 · career development · K08

Stearoyl-CoA Desaturase in Alcohol-Promoted Liver Tumorigenesis

Keane Lai · Beckman Research Institute · funded by National Institutes of Health

$195.6kAlcohol Consumption and Health Effects

2017–2021 · research · R01

Circadian Clock Control of Adipose Depot Development and Function

Ke Ma · Beckman Research Institute · funded by National Institutes of Health

$432.5kCircadian rhythm and melatonin

2017–2022 · cooperative agreement · U54

Combating Subclonal Evolution of Resistant Cancer Phenotypes

Andrea Hope Bild · Beckman Research Institute · funded by National Institutes of Health

$2.2MMathematical Biology Tumor Growth

2017–2021 · research · R01

Structural Basis of G-protein selectivity in GPCRs using Multiscale Dynamics

Sivaraj Sivaramakrishnan · Beckman Research Institute · funded by National Institutes of Health

$557kReceptor Mechanisms and Signaling

2017–2028 · research · R25

Preparing Oncology Advanced Practice Nurses as Generalists in Palliative Care

Betty R Ferrell · Beckman Research Institute · funded by National Institutes of Health

$183.1k

2017–2022 · research · R01

Targeting c-Myc and Proteasome Inhibitor Resistance in Multiple Myeloma

Yuan Chen · Beckman Research Institute · funded by National Institutes of Health

$581kUbiquitin and proteasome pathways

2017–2022 · cooperative agreement · U01

Noncoding RNA Biomarkers for Noninvasive and Early Detection of Pancreatic Cancer

Ajay Goel · Beckman Research Institute · funded by National Institutes of Health

$1.1M

2017–2018 · grant · DP3

T cell specificity and phenotypes in preclinical type 1 diabetes

Helena Kristiina Reijonen · Beckman Research Institute · funded by National Institutes of Health

$582.6kDiabetes and associated disorders

2017–2024 · research · R35

Human natural killer cells: Advancing biology and clinical applications

Michael A Caligiuri · Beckman Research Institute · funded by National Institutes of Health

$954.5kImmune Cell Function and Interaction

2017–2022 · research · R01

The role and mechanism of FTO in leukemogenesis and drug response

Jianjun Chen · Beckman Research Institute · funded by National Institutes of Health

$426.3kRNA modifications and cancer

2017–2022 · research · R01

Targeting microRNAs to eradicate leukemia stem cells

Ya-Huei Kuo · Beckman Research Institute · funded by National Institutes of Health

$497.1kMicroRNA in disease regulation

2017–2022 · research · R25

Preparing Oncology Advanced Practice Nurses as Generalists in Palliative Care

Betty R Ferrell · Beckman Research Institute · funded by National Institutes of Health

$310.8k

2017–2021 · research · R01

Targeting TET1 signaling to treat acute myeloid leukemia

Jianjun Chen · Beckman Research Institute · funded by National Institutes of Health

$457.3kAcute Myeloid Leukemia Research

2017–2028 · research · R25

Preparing Oncology Advanced Practice Nurses as Generalists in Palliative Care

Betty R Ferrell · Beckman Research Institute · funded by National Institutes of Health

$324k

2017–2024 · research · R35

Human natural killer cells: Advancing biology and clinical applications

Michael A Caligiuri · Beckman Research Institute · funded by National Institutes of Health

$992.2kImmune Cell Function and Interaction

2017–2018 · contract · N01

IGF::OT::IGF - PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES

Joseph Gold · Beckman Research Institute · funded by National Institutes of Health

$1.7M

2017–2020 · research · R01

CD25-mediated feedback control of BCR-signaling and its oncogenic mimics

Markus Müschen · Beckman Research Institute · funded by National Institutes of Health

$169.2k

2017–2020 · research · R00

Hypoxia-Suppressed Dicer and AGO1 Promote Angiogenesis

Zhen Bouman Chen · Beckman Research Institute · funded by National Institutes of Health

$249kCancer, Hypoxia, and Metabolism

2017–2021 · research · R01

Circadian Clock Control of Adipose Depot Development and Function

Ke Ma · Beckman Research Institute · funded by National Institutes of Health

$432.5kCircadian rhythm and melatonin

2017–2032 · research · R35

Human natural killer cells: Advancing biology and clinical applications

Michael A Caligiuri · Beckman Research Institute · funded by National Institutes of Health

$886.4k

2017–2027 · research · R01

Role of the unfolded protein response in pathological cardiac remodeling

Zhao Wang · Beckman Research Institute · funded by National Institutes of Health

$575.4k

2017–2028 · cooperative agreement · U01

Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer

Ajay Goel · Beckman Research Institute · funded by National Institutes of Health

$13.5k

2017–2028 · career development · K24

Mentoring the Next Generation of Geriatric Oncology and Supportive Care Researchers in Patient-Oriented Research to Improve the Care of Older Adults with Cancer

William Dale · Beckman Research Institute · funded by National Institutes of Health

$185.7k

2017–2023 · cooperative agreement · U54

Administrative Core

Andrea Hope Bild · Beckman Research Institute · funded by National Institutes of Health

2017–2023 · cooperative agreement · U54

Core 2: Computational Core

Jeffrey T Chang · Beckman Research Institute · funded by National Institutes of Health

2017–2023 · cooperative agreement · U54

Core 1: Translational Core

Philip J Moos · Beckman Research Institute · funded by National Institutes of Health

2017–2023 · cooperative agreement · U54

Project 2: Targeting Cooperative Phenotypes Common in Spatial Heterogeneity

Jeffrey T Chang · Beckman Research Institute · funded by National Institutes of Health

2016

Evaluation of tobacco and e-cigarette genotoxicity

Timothy O'Connor · Beckman Research Institute · funded by Office of the President, University of California

$408k

2016–2021 · research · R01

Mechanisms for Salivary Tumor Epithelial-Mesenchymal Transitions

David K. Ann · Beckman Research Institute · funded by National Institutes of Health

$425kSalivary Gland Tumors Diagnosis and Treatment

2016–2018 · grant · High Impact Pilot Award

Evaluation of tobacco and e-cigarette genotoxicity

Timothy O'Connor · Beckman Research Institute · funded by Office of the President, University of California

$408k

2016–2021 · research · R01

Control of B cell development and effector functions by microRNA-142

Mark P Boldin · Beckman Research Institute · funded by National Institutes of Health

$425k

2016–2021 · research · R50

Functional Analysis of Structure Specific Nucleases in Genome Stability and Cancers

Li Zheng · Beckman Research Institute · funded by National Institutes of Health

$282.3kDNA Repair Mechanisms

2016–2023 · research · R01

MicroRNA Biomarkers for Determining Treatment Response in Colorectal Cancer

Ajay Goel · Beckman Research Institute · funded by National Institutes of Health

$405kMicroRNA in disease regulation

2016–2022 · research · R01

Regulation of symmetric and asymmetric cell division during brain development

Qiang Lu · Beckman Research Institute · funded by National Institutes of Health

$371.9kNeurogenesis and neuroplasticity mechanisms

2016–2021 · training · T32

DNA Damage Response and Oncogenic Signaling

Timothy R O'Connor · Beckman Research Institute · funded by National Institutes of Health

$123.5k

2016–2018 · cooperative agreement · UH2

Impact of aging on the outcomes of a mouse model of chronic myeloid leukemia

Wenyong Chen · Beckman Research Institute · funded by National Institutes of Health

$51.4kChronic Myeloid Leukemia Treatments

2016–2020 · contract · N01

IGF::OT::IGF Production Assistance for Cellular Therapies (PACT)- Cell Processing Facilities

Michael Shaw · Beckman Research Institute · funded by National Institutes of Health

$180.1k

2016–2022 · research · R01

Reolysin-based combination therapy in relapsed multiple myeloma

Craig C. Hofmeister · Beckman Research Institute · funded by National Institutes of Health

$574.6kMultiple Myeloma Research and Treatments

2016–2021 · research · R01

Mechanisms for Salivary Tumor Epithelial-Mesenchymal Transitions

David K. Ann · Beckman Research Institute · funded by National Institutes of Health

$425kSalivary Gland Tumors Diagnosis and Treatment